http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016014047-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d779448e816f508915ebf0e60c0ba809 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0095 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-222 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-11 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-11 |
filingDate | 2015-09-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e88146c9774c6cc350c899aacfb2c7cb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_328288c5546aaece7938f36c4193ff07 |
publicationDate | 2016-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2016014047-A |
titleOfInvention | Treatment plan and treatment method for treating or improving visual impairment associated with endogenous retinoid deficiency |
abstract | A therapeutic plan and method for treating or ameliorating a visual impairment associated with a deficiency of endogenous retinoid in a subject. A method of treating a patient suffering from vision loss or impairment caused by retinoid deficiency, comprising: (a) a synthetic retinal that provides an alternative to endogenously produced 11-cis-retinal. Administering an initial therapeutically effective dose of the derivative to the patient; (b) refraining from administering an additional therapeutically effective dose of the synthetic retinal derivative to the patient for at least a one month rest period; (C) a method comprising administering an additional therapeutically effective dose of a synthetic retinal derivative to a patient. [Selection figure] None |
priorityDate | 2010-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 290.